146 related articles for article (PubMed ID: 34602296)
1. Abandoning node dissection for desmoplasia-negative encapsulated unifocal sporadic medullary thyroid cancer.
Machens A; Kaatzsch P; Lorenz K; Horn LC; Wickenhauser C; Schmid KW; Dralle H; Siebolts U
Surgery; 2022 Feb; 171(2):360-367. PubMed ID: 34602296
[TBL] [Abstract][Full Text] [Related]
2. Sporadic noninvasive medullary thyroid neoplasm: A desmoplasia-negative unifocal nonmetastatic tumor cured by hemithyroidectomy.
Dralle H; Brandenburg T; Weber F; Führer-Sakel D; Theurer S; Baba HA; Schmid KW; Machens A
Surgery; 2023 Dec; 174(6):1356-1362. PubMed ID: 37821265
[TBL] [Abstract][Full Text] [Related]
3. Risk Factors for Lateral Lymph Node Metastases in Patients With Sporadic Medullary Thyroid Carcinoma.
Wu X; Li B; Zheng C; Liu W; Hong T; He X
Technol Cancer Res Treat; 2020; 19():1533033820962089. PubMed ID: 32964812
[TBL] [Abstract][Full Text] [Related]
4. Large sporadic thyroid medullary carcinomas: predictive factors for lymph node involvement.
Aubert S; Berdelou A; Gnemmi V; Behal H; Caiazzo R; D'herbomez M; Pigny P; Wemeau JL; Carnaille B; Renaud F; Bouchindhomme B; Leteurtre E; Perrais M; Pattou F; Do Cao C
Virchows Arch; 2018 Mar; 472(3):461-468. PubMed ID: 29388012
[TBL] [Abstract][Full Text] [Related]
5. Metastatic Risk Profile of Microscopic Lymphatic and Venous Invasion in Medullary Thyroid Cancer.
Machens A; Lorenz K; Weber F; Dralle H
Horm Metab Res; 2021 Sep; 53(9):588-593. PubMed ID: 34496409
[TBL] [Abstract][Full Text] [Related]
6. [Extent of resection in intrathyroidal medullary thyroid cancer].
Lorenz K; Machens A; Siebolts U; Dralle H
Chirurg; 2020 Dec; 91(12):1017-1024. PubMed ID: 32989502
[TBL] [Abstract][Full Text] [Related]
7. Extent of surgery in localized, sporadic medullary thyroid carcinoma: Can we avoid central compartment lymph node dissection?
Das S; Jha CK; Singh PK
Surgery; 2023 Oct; 174(4):1094-1095. PubMed ID: 36639300
[No Abstract] [Full Text] [Related]
8. Breach of the thyroid capsule and lymph node capsule in node-positive papillary and medullary thyroid cancer: Different biology.
Machens A; Dralle H
Eur J Surg Oncol; 2015 Jun; 41(6):766-72. PubMed ID: 25468749
[TBL] [Abstract][Full Text] [Related]
9. Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer.
Scollo C; Baudin E; Travagli JP; Caillou B; Bellon N; Leboulleux S; Schlumberger M
J Clin Endocrinol Metab; 2003 May; 88(5):2070-5. PubMed ID: 12727956
[TBL] [Abstract][Full Text] [Related]
10. Timing and extension of lymphadenectomy in medullary thyroid carcinoma: A case series from a single institution.
Polistena A; Sanguinetti A; Lucchini R; Galasse S; Monacelli M; Avenia S; Boccolini A; Johnson LB; Avenia N
Int J Surg; 2017 May; 41 Suppl 1():S70-S74. PubMed ID: 28506418
[TBL] [Abstract][Full Text] [Related]
11. Biological relevance of medullary thyroid microcarcinoma.
Machens A; Dralle H
J Clin Endocrinol Metab; 2012 May; 97(5):1547-53. PubMed ID: 22399508
[TBL] [Abstract][Full Text] [Related]
12. Analysis of risk factors for cervical lymph node metastases in patients with sporadic medullary thyroid carcinoma.
Fan W; Xiao C; Wu F
J Int Med Res; 2018 May; 46(5):1982-1989. PubMed ID: 29569965
[TBL] [Abstract][Full Text] [Related]
13. Can intraoperative frozen section influence the extension of central neck dissection in cN0 papillary thyroid carcinoma?
Raffaelli M; De Crea C; Sessa L; Giustacchini P; Bellantone R; Lombardi CP
Langenbecks Arch Surg; 2013 Mar; 398(3):383-8. PubMed ID: 23207498
[TBL] [Abstract][Full Text] [Related]
14. Surgery for lymph node metastases of medullary thyroid carcinoma: A review.
Jin LX; Moley JF
Cancer; 2016 Feb; 122(3):358-66. PubMed ID: 26539937
[TBL] [Abstract][Full Text] [Related]
15. Comparing nodal with primary tumor desmoplasia uncovers metastatic patterns in multiple endocrine neoplasia 2B.
Machens A; Bensch C; Wickenhauser C; Dralle H; Lorenz K
Eur J Endocrinol; 2024 Jan; 190(1):K21-K25. PubMed ID: 38147465
[TBL] [Abstract][Full Text] [Related]
16. The prognostic value of lymph node ratio in Medullary thyroid carcinoma: A multi-center study.
Rozenblat T; Hirsch D; Robenshtok E; Grozinsky-Glasberg S; Gross DJ; Mazeh H; Benbassat C; Twito O; Levy S; Mizrachi A; Shpitzer T; Bachar G
Eur J Surg Oncol; 2020 Nov; 46(11):2023-2028. PubMed ID: 32389525
[TBL] [Abstract][Full Text] [Related]
17. Lymph node metastases in pediatric medullary thyroid carcinoma.
Oliver JR; Patel KN; Chang CM; Baldwin CK; Brar PC; Morris LGT; Givi B
Surgery; 2021 Sep; 170(3):736-742. PubMed ID: 33838880
[TBL] [Abstract][Full Text] [Related]
18. [Individualization of treatment in sporadic and hereditary medullary thyroid cancer].
Lorenz K; Machens A; Dralle H
Chirurgie (Heidelb); 2024 Mar; 95(3):186-191. PubMed ID: 38214736
[TBL] [Abstract][Full Text] [Related]
19. Skip metastases in thyroid cancer leaping the central lymph node compartment.
Machens A; Holzhausen HJ; Dralle H
Arch Surg; 2004 Jan; 139(1):43-5. PubMed ID: 14718274
[TBL] [Abstract][Full Text] [Related]
20. Prediction of biochemical cure in patients with medullary thyroid cancer.
Machens A; Lorenz K; Dralle H
Br J Surg; 2020 May; 107(6):695-704. PubMed ID: 32108330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
